Hannah's
Story
“It was just a little red bump on
her leg,” recalls Mary Ann Fischer about the beginning
of her daughter Hannah’s struggle to overcome
melanoma.
“Kids get bumps.” When she asked her pediatrician
to take a look, she was assured it was not a concern. But
it was growing. Several consultations with a number of doctors
in her area yielded the same answer: it was growing because
Hannah was growing. Spurred on by a mother’s intuition,
Fischer pressed to have the bump removed. Ten days later,
a pathology report was returned, confirming melanoma. Hannah
was just five years old.
For Hannah and the Fischers, countless trips to numerous
doctors at four different institutions preceded their first
visit to the University of Michigan Multidisciplinary Melanoma
Clinic. Additional surgery including a sentinel lymph node
biopsy and lymph node dissection revealed melanoma in two
of Hannah’s lymph nodes. “I wish we would have
come to Michigan right from the start,” says Mary Ann
Fischer. Hannah’s disease called for treatment beyond
surgery to check the cancer’s recurrence. The most common
approach is the use of the drug Interferon, but at Hannah’s
young age, other institutions were reluctant to provide Interferon
treatment. The team at Michigan believed the approach was
appropriate and began her treatment immediately. Although
she did experience the expected side effects – flu-like
symptoms, muscle aches and headaches – she tolerated
the regimen well. “She’s a strong girl,”
says Fischer.
Ken’s Story
For Ken Kraemer and his wife Bernadine, the journey to U-M
was more direct, but took longer. A suspicious spot on Kraemer’s
left temple remained virtually unchanged and represented “only
a nuisance” for nearly eight years before he decided
to have it removed in 1992. The spot returned the following
year, and Kraemer sought another consultation. “The
doctors weren’t sure what it was,” Kraemer recalls,
“so they referred me to Michigan.”
It
was only after the growth was removed and pathology reports
confirmed melanoma that Kraemer and his wife Bernadine worried.
“I never questioned that all would be ok,” says
Kraemer, “but I think my wife was more concerned.”
Additional surgeries were required to remove both surrounding
lymph nodes and any potentially cancerous areas bordering
the melanoma. Thankfully, in Kraemer’s case, no evidence
of spread to the lymph nodes was found.
The surprising face of melanoma
Hannah and Ken are only two of the over 1,100 new cases seen
in the U-M Cancer Center’s
Multidisciplinary Melanoma Clinic each year. Although their stories differ, they both
demonstrate the importance of vigilant self-screening and
timely diagnosis and treatment. One American dies every hour
of melanoma. The number of new cases continues to rise faster
than any other type of cancer. Currently, one in 37 people
born in the U.S. this year are projected to develop either
an invasive (below the top skin layer) or in situ (in the
top layer) melanoma over their lifetime. The presence of any
one of a long list of factors –family history, eye and
hair color, skin type, early-age sunburns, the presence of
many normal moles or any irregular appearing moles—
can significantly increase that risk. In 2004, 95,880 new
cases of invasive or in situ melanoma will be diagnosed in
the U.S. – over 1,600 in the state of Michigan. Just
how rare is Hannah’s case? Only about 3% of melanoma
cases occur in patients under the age of 20, and an even smaller
number are found in very young children. However, as reported
in the New England Journal of Medicine (Vol. 332 No. 10. 656-662),
in up to 60% of cases, decreased survival rates among children
have been attributed to delays in diagnosing the cancer, most
commonly due to physicians being hesitant to recognize melanoma
in children. (When found early, most melanomas are
curable. Please check your skin regularly using the
self-screening card.)
Many people assume melanoma afflicts only “sunworshippers”
who scoff at sunscreen. Mary Ann Fischer is quick to correct
that myth: “Melanoma isn’t as simple as that.
We’ve always been a very sun-safe family, and always
use sunscreen,” she says. “If it can strike a
perfectly healthy little kid like Hannah, we all need to learn
from that.”
In the Fischer family’s journey through diagnosis,
treatment and recovery, they discovered that one group with
a lot to learn is doctors. With great frustration, she recounts
a conversation with a friend whose husband had just been diagnosed
with melanoma. “My friend shared Hannah’s experience
with their doctor, who told her emphatically that there has
never been a 5-year-old diagnosed with melanoma – it
was impossible.” This anecdote, along with Ken Kraemer’s
experience, reveal the importance of remaining vigilant not
only in checking skin for problems, but in continuously following
up with doctors to consider every possibility. As Fischer
puts it, “follow your instincts and keep pushing until
you’re satisfied with the answers.” For both the
Fischers and the Kraemers, those answers were finally found
in the Multidisciplinary Melanoma Clinic at Michigan.
A typical day in the U-M melanoma clinic
“There’s no such thing,” says clinic director
Timothy Johnson, M.D. “Because every patient is different,
every day is unique.
That’s why comprehensive care in a multidisciplinary
setting is so important. There are no “one size fits
all” answers in treating cancer. The best treatment
is defined by how well it is individualized to the patient’s
specific case.” But certain constants define melanoma
care at Michigan, and help explain why Hannah Fischer and
Ken Kraemer – along with six in ten melanoma cases diagnosed
in the state – eventually came through the door of Dr.
Johnson’s clinic.
Clinic coordinator Amy Young-Sereno, R.N.,B.S.N., describes
the atmosphere of the clinic as controlled chaos. “It
might appear like that, but behind the scenes, everything
we do is designed to make the patient’s experience as
stress-free as possible. We understand that patients are full
of questions – and anxiety—and we work hard to
make sure that every question is addressed and that we use
the patient’s time wisely.” Young-Sereno notes
that much of their effort takes place before the patient even
arrives for an appointment.
“The first person you encounter when you call our clinic
is a registered nurse, who not only handles appointment scheduling
but can answer questions about the disease and, hopefully,
alleviate some initial concerns.” The nurse takes a
health history and begins to assemble the pieces necessary
to make the most out of the initial clinic consultation. The
clinic staff coordinates with the referring physician to ensure
that all necessary records and test results are sent to the
clinic nursing office before the appointment, often making
frequent follow-up calls when records don’t arrive in
time. As needed, the clinic nurse may also help the patient
connect with the Cancer Center’s social work staff to
address any psychosocial needs or concerns.
The patient’s prior test results are scrutinized by
the clinic’s dermatopathologist who renders an expert
opinion on the diagnosis before the clinic appointment. This
is a critical step in determining what additional tests, and
ultimately what treatment plan, will be re-commended. In a
significant number of cases – about 10-20% – the
original diagnosis and subsequent treatment plans are altered
somewhat after the U-M pathology review and consultation have
been completed.
Clinic
patients first see a dermatologist trained in skin oncology
for a thorough skin exam and further education about their
melanoma diagnosis and management. At this point, any additional
surgery is scheduled. Advanced cases are reviewed by the clinic’s
multidisciplinary tumor board, consisting of surgeons, medical
oncologists, radiation oncologists, pathologists, geneticists,
nurses and a specialized psychosocial team, all focusing on
melanoma. As with all multidisciplinary care at the Cancer
Center, this allows a team of experts to address cases from
every possible angle, ensuring a comprehensive diagnosis and
plan of attack.
“In the clinic, nothing’s more important than
the peace of mind of our patients,” says Johnson. “A
cancer diagnosis is perhaps life’s cruelest wake-up
call, and our staff is constantly aware of the psychological
impact cancer has on the patient and his or her whole family.”
In Hannah’s case, the staff knew that although she might
be too young to understand the implications of cancer, her
folks knew the risks. Recalling their first clinic visit,
Fischer recounts how several physicians consulting on the
case noted that they too were parents, and could understand
the difficult situation they faced. “Everyone was incredibly
accommodating and caring.”
Ken
Kraemer tells of a similar clinic experience. “What
stands out in my mind is the quality of the people. From our
initial check-in to the very last moment, they could not have
been more friendly, capable and interested in my case.”
Kraemer also recounts the concern he and his wife felt prior
to coming to U-M. “This was our first encounter with
the hospital, and we were overwhelmed by the number of people
being treated there. When cancer strikes you, it’s easy
to say ‘why me?’ or ‘I’m the only
one going through this.’ Well, that’s not even
close.” Seeing so many people going through what they
were facing was comforting to the Kraemers, but also raised
additional concerns. “We wondered whether, with so many
patients, we would be treated like a number. But just the
opposite proved true.”
The clinic staff also keeps in mind the important role of
the referring physician in the long-term wellbeing of their
patients. “We update our referring doctors on the status
of patients after surgery,” says Johnson. “They
play a key role in the long term success of the patient. That
doctor is our partner in melanoma care, so we want them to
be reassured about what we’re doing from the very start.”
Facing
the Future
Hannah celebrated her eighth birthday in February, cancer
free and, according to her parents, “a happy-go-lucky
kid.” As for Kraemer, although a fan of the state’s
other Big Ten university, he made a pact with his wife. “I
told her, ‘on the day I get the all-clear, I’ll
stand on the steps of the hospital and sing the Michigan fight
song.’” He did just that, and recently celebrated
the first anniversary of his Michigan serenade. For both families,
the risk of melanoma returning is real, but they remain optimistic.
“We’ve found that the key to success – before,
during and after treatment – is to stay upbeat and 100%
positive,” Kraemer says. “It’s easier said
than done, but good things happen when you do.”
For more information on the U-M Comprehensive Cancer Center’s
Multidisciplinary Melanoma Clinic, call the Cancer AnswerLine
at 1-800-865-1125 or visit their web
site.
return to top
|